Podcasts about Diabetic retinopathy

The Big Unlock Podcast · Scaling With Autonomous AI for Diabetic Retinopathy Screening – Podcast with Alvin Liu In this episode, Dr. T.Y. Alvin Liu, Inaugural Director, James P Gills Jr MD and Heather Gills AI Innovation Center at Johns Hopkins Medicine shares his journey in healthcare AI, with a focus on image analysis and real-world applications. Dr. Liu discusses the FDA-approved autonomous AI system for diabetic retinopathy screening, which enables early detection in primary care settings and improves screening adherence. He outlines successful AI implementations at Johns Hopkins, including prior authorization pilots using generative AI and the importance of operational understanding in deployment. He also discussed the intersection of value-based medicine and artificial intelligence, and the challenges of implementing successful AI programs.  At the enterprise level, Dr. Liu emphasizes the need for strong AI governance to assess safety, effectiveness, and ROI. He outlines key challenges for AI startups, especially around reimbursement and regulation, and urges them to pursue sustainable business models. He also suggests closer collaboration among startups, VCs, and integrated health systems to bridge the gap between innovation and real-world adoption, essential for scaling AI responsibly and delivering long-term value in healthcare. Take a listen.

Drs. Ramsudha Narala, Kat Talcott, and Sarwar Zahid join to preview the June 2025 edition of Retinal Physician, focusing on GLP-1RAs and diabetic retinopathy, DRCR.net trial updates, CRAO protocol implementation, and early career advice for attendings. Relevant Financial Disclosures: None

In this episode, we interview Christina Campero, an entrepreneurial force behind Prosperia, a tech startup focused on AI in healthcare. Christina discusses her professional journey, moving from a background in bioscience and healthcare consulting to co-founding Prosperia. The startup uses AI to scan retina images for early detection of diabetic retinopathy and other eye diseases, a crucial service in Mexico due to a high prevalence of diabetes and limited access to ophthalmologists. The conversation covers the development process of their AI model, partnerships with primary healthcare touchpoints, and the advantages of operating in Mexico. They also explore the challenges and breakthroughs in fundraising for a Latin American AI healthcare startup, including securing a seed round from a Swedish fund. The episode ends with a look at Prosperia's future goals, including expanding their AI applications to detect other health conditions.   If your company is looking to scale its AI initiatives, head over to Tesoro AI (www.tesoroai.com). We are experts in AI strategy, staff augmentation, and AI product development.   Founder Bio:   Cristina Campero graduated from the Faculty of Chemistry of the UNAM with a Master's Degree in Bioscience Enterprise from the University of Cambridge in the United Kingdom. She has dedicated her professional career to the transformation of ideas into commercial products with an impact on health, starting in her career as a consultant at McKinsey & Company and in start-ups, first as an Associate in business development and strategy at Wren Therapeutics (in Cambridge UK ) where she was in charge of portfolio prioritization and funding (£18M Series A in Dec. 2018), and now as CEO of PROSPERiA.      Time Stamps:   00:36 Christina's Professional Journey 04:00 Founding Prosperia and Developing Retinia 05:43 Addressing Diabetic Retinopathy with AI 07:10 Challenges in Diabetic Retinopathy Detection 09:32 AI's Role in Early Detection and Screening 13:33 How does the Retinia software diagnosis work 15:20 The role of AI versus human doctors 20:43 Building and Training AI Models 24:31 Balance between engineers and health care professionals 26:14 Creating a customer base that trusts AI diagnosis 32:53 Fundraising and Growth Strategies 40:45 Advantages of Fundraising in Latin America Compared to the U.S. 44:01 Future Plans and Innovations   Resources   Follow Darius Gant LinkedIn - https://www.linkedin.com/in/m-darius-gant-cpa-44650aa/ Company Website - www.tesoroai.com     Subscribe on Spotify: https://open.spotify.com/show/4uDVNgsK3iNeu7yU4Inu2n   Subscribe on Apple Podcast: https://podcasts.apple.com/ae/podcast/the-darius-gant-show/id1527996104   Company website: https://www.prosperia.health/es LinkedIn: https://www.linkedin.com/company/prosperia/ https://www.linkedin.com/in/cristina-campero-peredo-a87a15115/  

Dr. Rajesh Rao sits down with Dr. Sophie J. Bakri and medical student Marie-Michele Macaron to discuss their systematic Review and meta-analysis on the efficacy and safety of anti-VEGF and panretinal photocoagulation for the treatment of proliferative diabetic retinopathy. From their Ophthalmology Retina article, “Anti-VEGF Injections vs. Panretinal Photocoagulation Laser Therapy for Proliferative Diabetic Retinopathy: A Systematic Review and Meta-Analysis.” Anti-VEGF Injections vs. Panretinal Photocoagulation Laser Therapy for Proliferative Diabetic Retinopathy. Macaron, Marie-Michele et al. Ophthalmology Retina, Volume 9, Issue 2, 105 - 121.

In this episode, we review the high-yield topic ⁠⁠⁠⁠⁠⁠⁠⁠⁠Diabetic Retinopathy⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠from the Ophthalmology section at ⁠⁠⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

Diabetic retinopathy remains a leading cause of preventable blindness worldwide, and AI may facilitate screening, if such models continue to perform well when they are deployed in the real world. Coauthors Arthur Brant, MD, of Stanford University, and Sunny Virmani, MS, of Google join JAMA+ AI Editor in Chief Roy H. Perlis, MD, MSc, to discuss a new study published in JAMA Network Open. Related Content: Diabetic Retinopathy Is Massively Underscreened—an AI System Could Help Performance of a Deep Learning Diabetic Retinopathy Algorithm in India

On today's episode, we review current management of diabetic retinopathy with vitreoretinal surgeon Dr. Andrew Barkmeier and discuss new research on the impact of novel T2D GLP-1 RA and SGLT2i medications on diabetic retinopathy.   Subscribe to the podcast: https://mayoclinicophthalmology.podbean.com Follow and reach out to us on IG and X: @mayocliniceye

In this episode, Siddharth Adda and Dr. Sampath Rangasamy, Research Associate Professor at the Translational Genomics Research Institute sit down to discuss his journey researching therapeutics for diabetic retinopathy. Dr. Rangasamy, a lifelong Type-I diabetic, reveals how the disease motivated him to conduct research on angiopoietin-2, and contribute towards a potential therapeutic.

A JAMA study identified factors linked to loss to follow-up in diabetic retinopathy and macular edema patients, including male gender, distance from care, and sociodemographic disparities. In Vietnam, six months of levofloxacin therapy showed a non-significant reduction in multidrug-resistant tuberculosis, emphasizing the balance between benefits and tolerability. Finally, Phase II trial showed pancigromab's promise in addressing cancer cachexia, with weight gain and symptom improvement, supporting further research.

#ThisMorning on #BRN #Wellness #1919 | Diabetic Retinopathy Rates in Youth Signal a Potential Health Crisis  | Julie M. Rosenthal, MD, MS, Kellogg Eye Center | #Tunein: broadcastretirementnetwork.com #Aging, #Finance, #Lifestyle, #Privacy, #Retirement, #Wellness and #More - #Everyday | #Subscribe with #DiscountCode ‘BRN20'

In this episode I share my jet-lagged reflections after speaking at the Mary Tyler Moore Vision Initiative Symposium. As an ambassador for the initiative, I discuss the fight against diabetic retinopathy, the most common cause of vision loss in people with diabetes, and the ongoing advancements in diagnostics and treatments. I also address your questions, including the challenges of astigmatism, the discomfort of modern headlights, and long-term effects of nystagmus.  Takeaways: Diabetic Retinopathy Is a Leading Cause of Vision Loss: Dr. Flannery explains how diabetes damages the small blood vessels in the retina, leading to blindness if untreated, and highlights the importance of early detection. Mary Tyler Moore Vision Initiative: This nonprofit is advancing research and treatment options for diabetic retinopathy, focusing on reducing the devastating impact of this disease. Astigmatism and Night Driving: Dr. Flannery discusses the challenges astigmatism poses, especially with modern LED headlights, and highlights solutions like glasses, contact lenses, and specialized intraocular lenses. Nystagmus and Eye Movement: He explains why people with congenital nystagmus often don't perceive the motion of their eyes and debunks concerns about long-term damage from constant eye movement. The Power of Advocacy: Through his work with the Mary Tyler Moore initiative and engaging with fans, Dr. Flannery emphasizes the importance of education and community in addressing preventable vision loss. — To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! – http://www.patreon.com/glaucomflecken Also, be sure to check out the newsletter: https://glaucomflecken.com/glauc-to-me/ If you are interested in buying a book from one of our guests, check them all out here: https://www.amazon.com/shop/dr.glaucomflecken If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link:  Anatomy Warehouse Plus for 15% off use code: Glaucomflecken15 Today's episode is brought to you by DAX Copilot from Microsoft. DAX Copilot is your AI assistant for automating clinical documentation and workflows helping you be more efficient and reduce the administrative burdens that cause us to feel overwhelmed and burnt out. To learn more about how DAX Copilot can help improve healthcare experiences for both you and your patients visit aka.ms/knockknockhi. Join 6,000 physicians nationwide who trust physician-founded PearsonRavitz with their insurance needs. Give yourself peace of mind and go to PearsonRavitz to schedule your free one-on-one consultation with a disability insurance expert. That's http://ww.pearsonravitz.com/knockknock to get more information and take the first step toward protecting your income and future. Produced by Human Content Learn more about your ad choices. Visit megaphone.fm/adchoices

Sila Bal, MD, MPH, welcomes Vivienne Hau, MD, PhD, to review a case of a 56-year-old man with a history of ocular hypertension and type 2 diabetes who presented with mild nuclear sclerotic cataracts and a decrease in vision in both eyes. Dilated examination showed tortuous renal vasculature, scattered hemorrhages, cotton wool spots, and hard exudates in both eyes. Dr. Hau describes these clinical findings and explains next steps for diagnosing and treating this patient.

Welcome to Protecting Your Nest with Dr. Tony Hampton. Ajalah Efem, who lives in the South Bronx, the poorest part of NYC, had diabetes and was experiencing debilitating depression before she started following a low-carb diet. She reversed her severe t2 diabetes on a low-carb diet in a matter of weeks. She recently told her amazing story of healing in her speech at the Metabolic Revolution Rally (see links below). In this discussion, Dr. Tony and Ajalah talk about: (03:18) The metabolic revolution rally (08:15) Ajalah's diagnosis with Type 2 diabetes and how it felt to be given that diagnosis as a mom with 2 kids (15:00) Ajalah's diabetes symptoms and how they effected her life before she began following a low carb diet (19:21) The tipping point that caused Ajalah to get serious about fixing her health issues (30:48) Ajalah's experience trying keto for the first time (35:43) The health benefits Ajalah experienced being on the keto diet (41:02) Diabetic Retinopathy in patients with t2 diabetes (43:02) Access to real nutritional food in places like the Bronx and financial restrictions for poorer communities (47:45) Ajalah's family's response to the keto diet (50:30) Health improvements experienced by Ajalah's kids on the keto diet (55:48) The amazing impact that Ajalah's health journey has had on her neighbors, siblings, and surrounding community (01:03:46) What Ajalah would tell her past self who was struggling with depression and diabetes (01:05:20) Ajalah's career goals, health goals, and community transformation goals Thank you for listening to Protecting Your Nest. For additional resources and information, please see the links below.   Links:   Additional Links: Metabolic Revolution The Fox Family Food Fight (children's book by Michelle Hurn) Diet Doctor Society of Metabolic Health Practitioners Metabolic Multiplier   Ajalah Efem: Metabolic Revolution Speech   Dr. Tony Hampton: Linktree Instagram Account LinkedIn Account Ritmos Negros Podcast Q Med Symposium for Metabolic Health Lectures How Waking Up Every Day at 4:30 Can Change Your Life Keto Mojo

Dr. Steve Edelman, an endocrinologist living with Type 1 diabetes, is joined by Dr. Nik London, an ophthalmologist specializing in retinal diseases such as Diabetic Retinopathy and Diabetic Macular Edema. Throughout this episode, they discuss eye complications and their effects on individuals with diabetes. They go into depth and breakdown Diabetic Retinopathy—a common eye complication found in individuals with diabetes. Diabetic retinopathy is a leading cause of blindness among individuals with diabetes, but through education, regular checkups, and advancements in treatment, the risk of vision loss can be significantly reduced. They explore how the condition can develop, its treatments, and the importance of regular eye checkups for individuals with diabetes. Dr. London shares his professional insights and knowledge on protecting eye health, advancements in retinal care, and how early detection can prevent vision loss among individuals with diabetes..Key Topics:What is diabetic retinopathy, and how does it develop?The different stages of diabetic retinopathy.What is Diabetic Macular Edema?How can DME be prevented?The importance of regular eye checkups for individuals with diabetes.How diabetes affects eye health and vision?Advances in the treatment of diabetic retinopathy Anti-VEGF injections.How do these injections work in regard to Diabetic Retinopathy?The different methods for preventing and treating diabetic retinopathy.How can early intervention save vision in patients with diabetes?Why early intervention is important when it comes to eye health.What to expect during a retinal exam and treatment process.Learn More:Video: Eye Complications – Prevention, Early Detection, and Aggressive TreatmentVideo: Routine Eye Exams: The What, When, How and WhyLearn more about DME and Vabysmo  ★ Support this podcast ★

Research highlights alarming rates of diabetic retinopathy; an ophthalmologist shares what to know.Visit Health Lab to read the full story.The transcript for this episode can be found here.For the latest in health research and information, subscribe to our weekly newsletters.Health Lab is brought to you by the Michigan Medicine Department of Communication. Michigan Medicine is the academic medical center for the University of Michigan. Health Lab is a part of the Michigan Medicine Podcast Network. You can subscribe to Health Lab on Apple Podcasts, Spotify, Stitcher or wherever you listen to podcasts. Hosted on Acast. See acast.com/privacy for more information.

J. Daniel Diaz, MD, and Diana Shechtman, OD, FAAO, work side by side at Retinal Consultants of Miami. In this episode, Dr. Allen interviews them both to learn how they work together to serve their patients. Dr. Diaz and Dr. Shechtman agree that success starts with mutual respect and trust in each other and feel that collaborative care is the only way forward. Listen in as they discuss their backgrounds and the patient population they serve. They also share their thoughts on how other optometrists and ophthalmologists can collaborate to better serve their patients.  Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.

Innovating Ocular Disease Diagnosis, with Shiv Garg, EyeAI (North Fulton Business Radio, Episode 807) This episode of North Fulton Business Radio, hosted by John Ray, features Shiv Garg, a junior at Innovation Academy in Alpharetta and the founder of EyeAI. Shiv discusses the creation of EyeAI, a novel machine learning model for diagnosing ocular diseases. […] The post Innovating Ocular Disease Diagnosis, with Shiv Garg, EyeAI appeared first on Business RadioX ®.

In this episode, host Sandy Vance chats with Optomed Managing Director David Frasch about how AI can augment physicians' abilities and daily responsibilities in this space. Optomed is a handheld fundus camera manufacturer based in Finland and has been in operation for the last 20 years.In this episode, David will shed light on how Optomed cameras harness the power of AI to enhance the diagnosis and management of diabetic retinopathy. They explore the development of cutting-edge algorithms for medical diagnostics, the challenges of creating clinical algorithms without standardization, and the broad applications of AI across the healthcare sector. Stay tuned for a fascinating discussion on the transformative impact of AI in healthcare!In this episode, they talk about:How Optomed leverages AI to improve diagnosis and treatment of diabetic retinopathyDeveloping advanced algorithms for medical diagnosticsChallenges in creating optimal clinical algorithms without standardizationApplications of AI across various sectors in the healthcare industryAddressing ethical and privacy concerns in AI-driven healthcare solutionsEmerging trends in the application of AI in medicine and healthcareThe strategic partnership between AI Health and OptomedFuture collaborative opportunities between AI Health and physiciansA Little About David:With a decade of experience in medical sales within ophthalmology, David has recently excelled in building high-performance sales teams at BioTissue. As a director there, he successfully transformed the team's performance from worst to first, a process that was both challenging and rewarding. In his new role at Optomed, David aims to replicate this success by focusing on team development and growth. He is committed to growing the team in a controlled manner and laying a strong foundation for building a powerful and resilient organization.

On today's episode we dive into all things Diabetic Retinopathy with vitreoretinal surgeon Andrew Barkmeier, MD. 

Endocrinologist Robert Gabbay, MD, PhD, the ADA's chief scientific and medical officer, speaks with JAMA Medical News about clinical research highlights from the annual meeting, including some of the latest data on blockbuster weight loss medications, “game-changing” diabetes technologies, and a new use for a familiar drug. Related Content: New Data on GLP-1s, Diabetic Retinopathy, and CGMs—Highlights From the ADA's Scientific Sessions

Interview with David B. Rein, PhD, author of Prevalence of Diabetic Retinopathy in Health Care Settings—An Early Warning Sign? Hosted by Neil M. Bressler, MD. Related Content: Prevalence of Diabetic Retinopathy in Health Care Settings—An Early Warning Sign?

Interview with David B. Rein, PhD, author of Prevalence of Diabetic Retinopathy in Health Care Settings—An Early Warning Sign? Hosted by Neil M. Bressler, MD. Related Content: Prevalence of Diabetic Retinopathy in Health Care Settings—An Early Warning Sign?

Fighting Blindness is hosting a public engagement day this coming Saturday the 8th of June. Part of the Retina International World Congress taking place, the day offers an opportunity for people with sight loss to hear about the latest treatment advances and to quiz eye experts. To discuss this further, Alan Morrissey was joined by Áine Mae Crowley. Áine, who hails from Lahinch, lost her eyesight as a result of diabetic retinopathy. Picture (c) Fighting Blindness via Facebook

Drs. Yoshi Yonekawa and Sarwar Zahid join to preview the June 2024 edition of Retinal Physician, found online at http://www.retinalphysician.com.Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Join Dr. Marc. Grossman on the Natural Eye Care Podcast as he explores the fascinating connection between Alzheimer's disease and the eyes. Discover how early detection through retinal scans can provide crucial insights into Alzheimer's development, allowing for preventive measures and holistic management approaches.With over 43 years of experience as an integrative medical optometrist and author of five books on natural eye care, Dr. Grossman emphasizes the importance of a holistic approach to Alzheimer's disease prevention. Learn about the role of retinal imaging in detecting Alzheimer's in its early stages, along with its applications in diagnosing diabetic retinopathy, macular degeneration, and glaucoma.Explore potential underlying causes of Alzheimer's disease, including inflammation, blood-brain barrier damage, free radical damage, environmental toxins, gut health, sleep habits, and obesity. Dr. Grossman advocates for an integrative medical approach that includes regular exercise to enhance cognition and overall wellness.For more expert insights and comprehensive eye care resources, please visit NaturalEyeCare.com. Stay informed, proactive, and empowered in safeguarding your precious gift of sight with Dr. Marc Grossman and the Natural Eye Care Podcast. Don't miss out on valuable eye care information!

We discuss the promising phase I results of the Helios trial studying AXPAXLI  TKI inhibitor implant for diabetic retinopathy with Dr. Dilsher Dhoot of California Retina Consultants.

While optometry school was a last-minute decision for her, Dr. Julie Rodman knows it was the best decision she ever made. During her residency at the VA, she discovered her passion for working with students and watching them grow. Today, as a professor at Nova Southeastern University, she teaches the retina course and serves as the Chief of the Broward Eye Care Institute, exposing her students to a wide variety of pathologies in the real world. She also spent several years as the residency education coordinator and now runs a resident case report contest for the Optometric Retina Society. Her early introduction to OCT supercharged her passion for retina, so much so that she wrote a book about OCT-Angiography in 2019. Currently, she is working on two studies focused on geographic atrophy and diabetic retinopathy. Key Moments:1:37 Dr. Julie Rodman's path to optometry3:38 From residency to academia4:57 Teaching retina and running the clinic6:55 The ‘sexiness' of retina9:30 Dr. Rodman's research in retina11:05 Why she loves optometry13:59 A shout out to the power of OCT-A18:38 The role of optometry21:52 Residency programs25:28 Dr. Allen's learnings from his own residency30:10 Dr. Rodman's two current studies in geographic atrophy and diabetic retinopathy Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.

Dr. Marianeli Rodriguez joins to preview the April 2024 edition of Retinal Physician, found online at http://www.retinalphysician.com.Relevant Financial Disclosures: Dr. Sridhar has consulted for Genentech and Regeneron.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Dr. Sherrol Reynolds has three key passions: diversity and representation, mentorship, and high-quality eye health care. This has led her to become a strong voice in optometry focused on advocating for the profession's role in overall healthcare with a goal of increasing communication and collaboration between optometrists and other members of their patients' healthcare team. She has won numerous awards and held several key leadership positions for the National Optometric Association, Optometric Retina Society, the National Eye Institute, Prevent Blindness, and the Florida Optometric Society. As a leader in diabetes and diabetic retinopathy education, she is changing the narrative for patients with diabetes and their healthcare providers so that no one unnecessarily loses their vision due to diabetes like her aunt did. Ultimately, she wants every human to have access to high-quality healthcare.  Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.

Drs. Avni Finn and Sarwar Zahid join to discuss three recent publications from major ophthalmology journals.Diabetic Retinopathy and Quality of Life (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2814583)Artificial Intelligence in Ophthalmology Review (https://www.ophthalmologyretina.org/article/S2468-6530(24)00044-7/abstract)Proliferative Sickle Cell Retinopathy Surgical Outcomes (https://www.ophthalmologyretina.org/article/S2468-6530(24)00049-6/abstract)Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

The Tom Ficklin Show: Combatting Diabetic Retinopathy by WNHH Community Radio

This episode covers diabetic retinopathy.Written notes can be found at https://zerotofinals.com/medicine/ophthalmology/diabeticretinopathy/ or in the ophthalmology section of the 2nd edition of the Zero to Finals medicine book.The audio in the episode was expertly edited by Harry Watchman.

Michael Cymbor, OD, FAAO, radiates with a passion for optometry, especially when it comes to the connection between exercise, muscle mass, and ocular health. He discusses the research and how different types and intensities of exercise should be considered for different conditions. He knows each patient will have a different reaction to “you should exercise more,” so he makes sure to meet them where they are regarding their exercise routine. Dr. Cymbor truly enjoys mentoring optometry students, as well as tapping into his creative side, which led to the creation of hid video: “Night of the Living DEModex.”  Key Moments: 2:49 Dr. Cymbor's path to a career in optometry 5:13 What brought Dr. Cymbor to State College, PA (“Happy Valley” … home of Penn State University) 6:20 The story behind his video: “The Night of the Living Demodex” 11:46 Dr. Cymbor's passion for glaucoma care and how it led to The Glaucoma Institute in partnership with his ophthalmologist partner 14:55 The types of optometrists who gravitate towards a glaucoma specialty 19:09 Current views on glaucoma research 21:08 Dry eye and ocular surface disease 27:30 Finding your sense of purpose 30:00 The value and importance of mentorship 33:10 Exercise and ocular health 38:09 How muscle mass impacts blood sugar levels 41:29 Exercise and eye pressure as it relates to glaucoma 44:05 Research into exercise and stress management 48:10 “Meeting patients where they are” regarding exercise 51:55 The Pickleball effect 54:00 The importance of earlier intervention to improve outcomes Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.

Molecular Hydrogen is surging in popularity as a potential treatment for a wide range of conditions, including eye diseases. Is this fascination with molecular hydrogen merely another passing supplement trend? Is there a substantive basis for considering it as a therapeutic option? Dr. Marc Grossman is a Holistic Optometrist and Acupuncturist. Check out  https://www.naturaleyecare.com/ to find the supplements described in this episode and a wealth of vision knowledge.

Jeffry Gerson always knew he wanted to be in the medical field, but having an aversion to blood and finding a positive role model led him to pursue optometry. Today, he practices at a collaborative OD/MD practice and is a prolific lecturer and writer who enjoys encouraging young people to explore optometry. He also partners with industry to help advise on new products and technologies, treatment protocols, and patient care. Over the years, he has developed a clear passion for the retina, especially caring for patients with age-related macular degeneration and diabetic retinopathy. When it comes to patient education, Dr. Gerson is most excited about finding disease early so that he can start the conversation with his patients to put them on the right path. He and his wife also prioritize volunteering and giving back to their community, from going on missions and providing free eye exams to co-chairing a charity event that focuses on helping people with addiction. Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.

This week on Knock Knock Eye, Will talks about the difference between doing keynote speeches with the Wife and Death Show, before going into the main topic for the day, diabetic retinopathy. It's one of the leading causes of blindness and is very common with those who are Diabetic.  — We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! – www.patreon.com/glaucomflecken    Today's episode is brought to you by the Nuance Dragon Ambient Experience (DAX). It's like having a virtual Jonathan in your pocket. If you would like to learn more about DAX, check out http://nuance.com/discoverDAX and ask your provider for the DAX experience. Produced by Human Content Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Fardink shares the latest in eye care news and trends. Learn about Omega-3s on Diabetic Retinopathy, Smart Contact Lenses, Corneal Endothelial Cell Therapy, and More.

In every episode of New Insight, Veeral Sheth, MD, Director of Clinical Trials at University Retina in Chicago, takes an in-depth look at the biggest news in ophthalmology and the behind the scenes work involved in eye care, with a rotation of guest experts involved in ophthalmic research, development, and clinical care. The latest episode of New Insight features a conversation with Ocuphire Pharma's CEO on the company's flagship retinal product and leading a small, but high-powered research team. Episode Highlights: 0:04 Introduction 1:23 History of Ocuphire Pharma 3:50 Leading a small, high-functioning team 6:41 Magrath's background and journey 11:02 APX3330 for Diabetic Retinopathy 15:20 2024 Plans for Ocuphire 18:53 Addressing unmet needs 20:20 Outro Every episode of New Insight is available on HCPLive.com and be sure to subscribe to our channel on Spotify and Apple Podcasts. Please direct any podcast-related inquiries to show producer Connor Iapoce at ciapoce@mjhlifesciences.com.

Interview with Sophia Y. Wang, MD, MS, author of Social Determinants of Health and Perceived Barriers to Care in Diabetic Retinopathy Screening. Hosted by Neil Bressler, MD. Related Content: Social Determinants of Health and Perceived Barriers to Care in Diabetic Retinopathy Screening

Drs. Ajay Kuriyan and Lediana Goduni preview the October 2023 issue of Retinal Physician, found online at http://www.retinalphysician.com. Topics covered include clinical trials in diabetic retinopathy, current paradigms in diabetic retinopathy treatment, screening for diabetic retinopathy, and more!Relevant Financial Disclosures: Dr. Sridhar is a consultant for Allergan, Alimera, Genentech, and Regeneron. Dr. Kuriyan has received research funding from Genentech and Regeneron.You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

This podcast is about big ideas on how technology is making life better for people with vision loss. When we buy a product off the shelf, we rarely think about how much work went into getting it there. Between initial conception and going to market, life-changing technology requires a rigorous testing and development process. That is especially true when it comes to accessible technology for people who are blind or visually impaired. For this episode, Dr. Cal spoke to Jay Cormier, the President and CEO of Eyedaptic, a company that specializes in vision-enhancement technology. Their flagship product, the EYE5, provides immense benefits to people with Age-Related Macular Degeneration, Diabetic Retinopathy, and other low-vision diseases. But this product didn't arrive by magic. It took years of planning, testing, and internal development to bring this technology to market. This episode also features JR Rizzo, who is a professor and researcher of medicine and engineering at NYU — and a medical doctor. JR and his research team are developing a wearable “backpack” navigation system that uses sophisticated camera, computer, and sensor technology. JR discussed both the practical and technological challenges of creating such a sophisticated project, along with the importance of beta testing and feedback.   The Big Takeaways: The importance of testing: There's no straight line between the initial idea and the final product. It's more of a wheel, that rolls along with the power of testing and feedback. It's extremely important to have a wide range of beta testers engage with the product. Their experience with it can highlight unexpected blind spots and create opportunities to make something even greater than originally anticipated. Anticipating needs: When it comes to products like the EYE5, developers need to anticipate that its users will have evolving needs as their visual acuity deteriorates. So part of the development process involves anticipating what those needs will be and finding a way to deliver new features as users need them. Changing on the fly: Sometimes, we receive feedback we were never expecting. When JR Rizzo received some surprise reactions to his backpack device, he had to reconsider his approach and re-examine his fundamental design. Future-Casting: When Jay Cormier and his team at Eyedaptic first started designing the EYE5 device, they were already considering what the product would look like in the future, and how it would evolve. To that end, they submitted certain patents many years ahead of when they thought they'd need them — and now, they're finally being put to use.   Tweetables: “I'm no Steve Jobs and I don't know better than our users. So the best thing to do is give them a choice and see what happens.” — Jay Cormier, President & CEO of Eyedaptic “I started to think a little bit more about … assistive technologies. … And, I thought about trying to build in and integrate other sensory inputs that we may not have natively … to augment our existing capabilities.” — JR Rizzo, NYU Professor of Medicine and Engineering “I think the way we've always looked at it is the right way, which is you put the user, the end user, front and center, and they're really your guide, if you will. And we've always done that even in the beginning when we start development of a project.” – Jay Cormier “When we put a 10-pound backpack on some colleagues, they offered some fairly critical feedback that it was way too heavy and they would never wear it. … They were like … it's a non-starter.” — JR Rizzo   Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss.   Pertinent Links Lighthouse Guild Eyedaptic Rizzo Lab

Mohammad Rafieetary, OD, FAAO, has practiced for nearly 30 years at Charles Retina Institute in Tennessee and Mississippi. He loves being about to closely co-manage his patients alongside his Retina Specialist MD colleagues, including his own son who recently joined that practice. Dr. Rafieetary has always been on the cutting edge of innovations in retina and is excited to see how advanced imaging and AI will continue to impact the future of patient care. The doctors discuss the challenges of caring for patients with diabetes and the new tools and treatments on the horizon. Most importantly, Dr. Rafieetary is passionate about giving back to optometry - whether that be lecturing, mentoring, working with industry, sitting on Boards, or serving as president of the Optometric Retina Society. He encourages more optometrists to “feed and care for the tree,” so that we can all benefit from the fruits of our labor.Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media. For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/ Visit https://odcommunity.com/ to learn more about FluoreSCENE Media. 

In this episode, my guest is Jeffrey Goldberg, MD, PhD, professor and chair of the department of ophthalmology at the Byers Eye Institute at Stanford University. His clinical and research efforts focus on retinal and optic nerve diseases such as glaucoma and discovering stem cell and nanotechnology treatments to cure blindness. We discuss how to maintain and improve eye health throughout life, the advantages and disadvantages of corrective lenses, including if you should wear “readers,” the use and risks of contact lenses, considerations for LASIK eye surgery, floaters, dry eye, the importance of sunlight and UV protection and specific exercises to improve eye and vision health. Dr. Goldberg also explains age-related conditions: cataracts, glaucoma, macular degeneration and diabetic retinopathy; and the behavioral and supplementation-based, prescription and surgical tools used to promote eye health. This episode provides essential tools for listeners of any age and background to maintain eye health and offset vision loss. For the full show notes, visit hubermanlab.com. Thank you to our sponsors AG1 (Athletic Greens): https://athleticgreens.com/huberman Maui Nui Venison: https://mauinuivenison.com/huberman LMNT: https://drinklmnt.com/huberman  Eight Sleep: https://eightsleep.com/huberman  InsideTracker: https://insidetracker.com/huberman  Momentous: https://livemomentous.com/huberman Timestamps (00:00:00) Dr. Jeffrey Goldberg (00:03:08) Sponsors: Maui Nui, LMNT, Eight Sleep (00:06:29) Childhood & Eye Exams (00:11:36) Eye Misalignment & Recovery (00:20:38) Myopia (Near-Sightedness), Children & Sunlight (00:30:04) Sponsor: AG1 (Athletic Greens) (00:31:18) Eye Safety & Protection; Eye Hygiene (00:40:07) Adults & Eye Exams; Optometrist vs Ophthalmologist (00:46:35) Presbyopia (Age-Related Vision Decline), Reading Glasses (00:54:54) Reading Glasses: Use & Recommendations (00:58:34) Night Vision & Glasses (01:02:55) Sponsor: InsideTracker (01:03:54) Corrective Eye Glasses, Exercises (01:09:52) Near-Far Exercise & Presbyopia; Smooth Pursuit Exercise & Concussion (01:13:25) Supranormal Vision & Performance Training (01:19:11) 20/20 Vision; Visual Acuity (01:24:51) Contact Lenses: Use, Risks & Aging (01:31:34) UV Protection & Cataracts, “Blue Blockers” (01:38:20) Light Sensitivity & Eye Color (01:40:29) LASIK Eye Surgery (01:46:26) Dry Eye, Tears & Age (01:53:24) Dry Eye, Serum Tears & Preservative-Free Artificial Tears; PRP (02:00:46) Vision Loss: Cataracts, Glaucoma (02:09:23) Age-Related Macular Degeneration, Dry & Wet Forms (02:14:02) Diabetic Retinopathy, Type I vs Type II Diabetes (02:18:54) Diabetic Retinopathy Treatment, Blood Pressure (02:22:17) Glaucoma Screening & Treatment (02:28:07) Smoking, Vaping & Vision Diseases; Cannabis & Eye Pressure (02:35:13) Eye Pressure & Sleep Position (02:37:48) Macular Degeneration, Optic Neuropathies & Red-Light Therapy (02:42:23) “Floaters” (02:45:29) Eye Twitching (02:48:10) AREDS2 Supplementation & Age-Related Macular Degeneration (02:53:39) Glaucoma & Vitamin B3 Supplementation (02:58:42) Retinal Imaging & Neurodegeneration Screening, Multiple Sclerosis (03:06:30) Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Momentous, Social Media, Neural Network Newsletter Title Card Photo Credit: Mike Blabac Disclaimer